This message was sent to ##Email##
|
|
|
|
|
SCAI
SCAI, IAC Cardiovascular Catheterization and other sponsoring organizations are pleased to announce the opportunity to comment on the proposed IAC Standards and Guidelines for Cardiovascular Catheterization Accreditation, prior to final publication in concert with the launch of the new accreditation program later this fall.
Beginning Sept. 1, the public may visit the IAC website at intersocietal.org/iac/comment_period_cath.htm to comment on any of the proposed standards until Sept. 30. In order to provide comments, the IAC Comment Form must be completed and submitted electronically by the provided deadline.
READ MORE
SCAI
SCAI submitted comments on Sept. 6 to the Centers for Medicare & Medicaid Services (CMS) in response to the 2018 Medicare Physician Fee Schedule (MPFS) proposed rule. In the rule, CMS proposed “blending” the non-surgical and surgical malpractice factors used in rate setting for cardiology procedures. This proposal would negatively impact SCAI members with a reduction in values for all interventional cardiology procedure codes (approximately 10 percent reduction across the board).
SCAI’s Advocacy Committee Chairs Drs. Osvaldo Gigliotti and Dmitriy Feldman took quick action to engage the CMS on this issue, with the CMS granting SCAI a call on July 24, 2017. During the call, CMS staff noted that the recommendation of appropriate crosswalks for malpractice factors has been well-received by CMS in the past, resulting in CMS revising their position.
SCAI has also reached out to garner the support of the AMA and ACC on this issue, and all entities are in agreement with recommending a crosswalk to cardiac surgery’s surgical malpractice factor in establishing a surgical malpractice factor for cardiology/interventional cardiology.
SCAI is asking members to take a moment to submit personal comments to CMS on the 2018 MPFS proposed rule in support of SCAI’s comments, attesting to the higher, differential in malpractice premiums interventional cardiologists pay as compared to their non-invasive cardiovascular colleagues. For the link to submit comments and a sample comment statement, click here.
|
Promoted by
|
|
|
|
 |
TCTMD
Abbott Vascular is calling a halt to sales of the Absorb bioresorbable vascular scaffold as of Sept. 14, attributing the decision to "low commercial sales."
"We pioneered bioresorbable technology because we believe it offers patients the possibility of life without permanent metallic implants, and we will continue work on a next-generation bioresorbable device," the company announced on its website.
READ MORE
Science Direct
In the absence of universal healthcare coverage, uninsured and underinsured depend on the medical safety net for medical and procedural care. For a large proportion of uninsured patients with more acute presentation, percutaneous coronary intervention-related outcomes of in-hospital mortality was only marginally higher in safety-net hospitals (SNH) compared with non-SNHs, whereas periprocedural bleeding and acute kidney injury were similar.
READ MORE
Advertisement
Pulsara
St. Elizabeth Healthcare, in Edgewood, Kentucky, serves a population of more than 400,000 across the Greater Cincinnati area, from Northern Kentucky to Indiana and Ohio. At St. Elizabeth, like most health systems in the U.S., there was no overarching way to organize all the different cardiac team members and stakeholders, which could cause treatment delays and disorganization. After adopting a set of recommended changes in the process of responding to heart attack patients including the implementation of Pulsara, the time from first medical contact to the moment of artery-opening treatment dropped 30 percent. See the full story here.
READ MORE
|
Cardiovascular Business
Survival with favorable quality of life improved among patients with refractory out-of-hospital ventricular fibrillation/ventricular tachycardia cardiac arrest when they were quickly taken to a cardiac catheterization laboratory for extracorporeal life support and revascularization, as opposed to being treated with prolonged resuscitation efforts at the scene of their heart attack, according to new research.
READ MORE
Healio
Administering IV fentanyl during percutaneous coronary intervention (PCI) delayed the absorption of ticagrelor by as many as four hours, according to a poster presented at the European Society of Cardiology Congress.
It is common to use opiates such as fentanyl during PCI in the United States, but not in other countries, presenter John W. (Bill) McEvoy, MBBCh, MEHP, MHS, assistant professor of medicine and epidemiology at Johns Hopkins Medicine and a Cardiology Today Next Gen Innovator, told Cardiology Today.
READ MORE
 |
|
Resolute Onyx™ DES is the next great advance in DES performance. Combining two powerful stent technologies — Continuous Sinusoid Technology and Core Wire Technology — Resolute Onyx™ DES offers exceptional deliverability, enhanced visibility, and the first 4.5- and 5.0-mm
DES sizes. Learn more at resoluteonyx.com ISW
© 2017 Medtronic. UC201802492EN
|
|
Medscape
"Triple-screening" older men for abdominal aortic aneurysm, peripheral arterial disease and hypertension reduced five-year mortality by 7 percent, randomized trial results show.
In the population-based Viborg Vascular trial, 65- to 74-year-old men in central Denmark were randomized to triple screening or no screening. Those found to be positive for any of these conditions then received treatment, including statins and aspirin.
READ MORE
Healio
Patients with a history of myocardial infarction who were treated with low-dose ticagrelor had less risk for bleeding after one year, according to a study published in the Journal of the American College of Cardiology.
Although patients continued to have risk for recurrent long-term atherothrombotic events, antithrombotic benefit conferred by low-dose ticagrelor (Brilinta, AstraZeneca) remained consistent from one year to three years, according to the researchers.
READ MORE
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
